Jamal Sarvari
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 40
- Hepatitis B Virus Studies 21
- Cervical Cancer and HPV Research 7
- Liver Disease Diagnosis and Treatment 7
- Cytomegalovirus and herpesvirus research 6
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- Mohammad Motamedifar (16 shared papers)Seyed Younes Hosseini (35 shared papers)Eskandar Kamali‐Sarvestani (5 shared papers)Behrouz Gharesi‐Fard (5 shared papers)Akbar Safaei (10 shared papers)Hadi Sedigh Ebrahim‐Saraie (4 shared papers)Neda Pirbonyeh (10 shared papers)Afagh Moattari (16 shared papers)
In The Last Decade
Jamal Sarvari
91 papers receiving 921 citations
Peers
Comparison fields: 5 of 82
- Molecular Medicine 142
- Applied Microbiology and Biotechnology 51
- Hepatology 133
- Epidemiology 284
- Endocrinology 45
Countries citing papers authored by Jamal Sarvari
This map shows the geographic impact of Jamal Sarvari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Sarvari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Sarvari more than expected).
Fields of papers citing papers by Jamal Sarvari
This network shows the impact of papers produced by Jamal Sarvari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Sarvari. The network helps show where Jamal Sarvari may publish in the future.
Co-authors
The 25 scholars most cited alongside Jamal Sarvari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 68 | |
| 2 | 2017 | 55 | |
| 3 | 2021 | 41 | |
| 4 | 2006 | 36 | |
| 5 | 2015 | 30 | |
| 6 | 2015 | 29 | |
| 7 | 2018 | 29 | |
| 8 | 2013 | 28 | |
| 9 | 2015 | 25 | |
| 10 | Antibiotic susceptibility pattern and identification of extended spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae from Shiraz, Iran. | 2016 | 25 |
| 11 | 2017 | 25 | |
| 12 | 2019 | 24 | |
| 13 | 2019 | 23 | |
| 14 | 2014 | 23 | |
| 15 | 2016 | 22 | |
| 16 | 2013 | 19 | |
| 17 | 2012 | 18 | |
| 18 | Blocking of SMAD4 expression by shRNA effectively inhibits fibrogenesis of human hepatic stellate cells. | 2015 | 18 |
| 19 | 2012 | 18 | |
| 20 | 2015 | 16 |
About Jamal Sarvari
Jamal Sarvari is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Oncology and Immunology, having authored 96 papers that have together received 935 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (14 papers), Antibiotic Resistance in Bacteria (8 papers), Cervical Cancer and HPV Research (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Molecular Medicine (142 citations), Applied Microbiology and Biotechnology (51 citations), Hepatology (133 citations), Epidemiology (284 citations) and Endocrinology (45 citations). Jamal Sarvari has collaborated with scholars based in Iran, Japan and Belgium. Frequent co-authors include Mohammad Motamedifar, Seyed Younes Hosseini, Eskandar Kamali‐Sarvestani, Behrouz Gharesi‐Fard, Akbar Safaei, Hadi Sedigh Ebrahim‐Saraie, Neda Pirbonyeh, Afagh Moattari, Shahab Mahmoudvand and Zahra Mojtahedi. Their work appears in journals such as Archives of Virology, Current Microbiology, Clinical Biochemistry, Immunologic Research and Infection Genetics and Evolution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.